This is consistent with previous studies in non-AD models, where capsaicin was also shown to reduce NF-KB activation and inhibit COX-2 activity, decreasing TNF-α, IL-6, and IFN-γ levels in a dose-dependent manner [52,53]. Here, PTGS2 is linked to Alzheimer disease.